secwatch.observer — SEC 8-K summary
======================================

Issuer:     EyePoint, Inc. (EYPT)
CIK:        0001314102
Form:       8-K
Filed at:   2023-01-06T23:59:59+00:00
Accession:  0000950170-23-000355
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

EyePoint prelim FY2022 net product revenue >$39.5M; Duker promoted to President & COO
--------------------------------------------------------------------------------

- FY2022 net product revenue prelim >$39.5M, up from $35.3M in FY2021.
- Cash and investments ~$144M as of Dec 31, 2022.
- Jay Duker promoted to President & COO; base salary $581K, target bonus 55%, equity grants of 85K options and 45K RSUs.
- Phase 2 DAVIO 2 (wet AMD) topline six-month data expected 4Q 2023; enrollment on track.
- Phase 2 PAVIA (NPDR) enrollment completion expected by 4Q 2023; DME Phase 2 initiation planned 4Q 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314102/000095017023000355/0000950170-23-000355-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314102/000095017023000355/eypt-20230103.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-000355

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer